ImmunityBio (IBRX) Interest Coverage Ratio Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 79.36% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 29.25% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -16.86% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.78% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 40.09% |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | -8.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.52% |
| Dec 31, 2025 | -43.54% |
| Sep 30, 2025 | 12.36% |
| Jun 30, 2025 | 17.52% |
| Mar 31, 2025 | 28.06% |
| Dec 31, 2024 | 46.74% |
| Sep 30, 2024 | 49.94% |
| Jun 30, 2024 | 48.22% |
| Mar 31, 2024 | 50.86% |
| Dec 31, 2023 | -169.63% |
| Sep 30, 2023 | 57.40% |
| Jun 30, 2023 | 52.07% |
| Mar 31, 2023 | 42.25% |
| Mar 31, 2021 | 68.33% |
| Dec 31, 2020 | 75.57% |
| Sep 30, 2020 | 21.93% |
| Jun 30, 2020 | 46.28% |
| Mar 31, 2020 | 69.55% |